Clinical Trial Update: Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tolvaptan for acute congestion in congestive heart failure has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Duke University | Conditions: Heart Failure, Dyspnea | Phase 3 | Status: COMPLETED | Results posted: 2017-04-27